The Safety and Short-Term Efficacy of Aliskiren in the Treatment of Immunoglobulin A Nephropathy – A Randomized Cross-Over Study

BACKGROUND: Laboratory research and previous study suggest that aliskiren, a direct renin inhibitor, has anti-proteinuric effects. We conducted a randomized crossover study to evaluate the anti-proteinuric effect of aliskiren in patients with immunoglobulin A (IgA) nephropathy. METHODS: We studied 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Szeto, Cheuk-Chun, Kwan, Bonnie Ching-Ha, Chow, Kai-Ming, Leung, Chi-Bon, Li, Philip Kam-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651209/
https://www.ncbi.nlm.nih.gov/pubmed/23675422
http://dx.doi.org/10.1371/journal.pone.0062736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651209/
https://www.ncbi.nlm.nih.gov/pubmed/23675422
http://dx.doi.org/10.1371/journal.pone.0062736

Ejemplares similares